Yuhan Corporation and Shinhung Sign Business Agreement for Joint Implant Venture

Comprehensive Cooperative System Including Planning, Marketing, and Sales

Yuhan Corporation and Shinhung, the longest-standing dental company in Korea, announced on July 25 that they have signed a business agreement to jointly pursue an implant business.

Lee Yongik, CEO of Shinheung (left), and Cho Wookje, CEO of Yuhan Corporation (right), are posing for a commemorative photo after signing a business agreement. Yuhan Corporation

The two companies plan to swiftly launch the 'Yuhan Evertis' implant and to establish a comprehensive cooperative system that includes joint planning, marketing, and sales of all dental medical devices and pharmaceuticals.

The most important requirement for an implant is superior quality. Shinhung's Evertis implant has established itself as a reliable product based on its excellent quality, and Yuhan Corporation has also been paying close attention to it for an extended period.

According to Yuhan Corporation, the Evertis implant has significantly improved quality stability by increasing the automation rate of its production process, fundamentally eliminating human error. In addition, ongoing research results have confirmed a cumulative survival rate of over 98%.

Yuhan Corporation CEO Cho Wookje stated, "We hope that the outstanding quality of the Evertis implant, combined with the synergy between Yuhan Corporation and Shinhung, will lead to expanded sales and contribute to improving the nation's oral health."

Shinhung CEO Lee Yongik also commented, "We expect that the Evertis implant, now under the Yuhan brand, will increase product recognition among dentists and patients, making it much easier for dentists to convey the product's excellence to their patients."

This content was produced with the assistance of AI translation services.